US Patent Issued to Zetagen Therapeutics on May 27 for "Methods and compositions for treating cancer" (New York, Massachusetts Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,310,962, issued on May 27, was assigned to Zetagen Therapeutics Inc. (Syracuse, N.Y.).

"Methods and compositions for treating cancer" was invented by Bryan S. Margulies (Liverpool, N.Y.) and Nikhil A. Thakur (Andover, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to methods and compositions for treating cancer by administering opioid growth factor receptor (OGFR) antagonists. In particular, the present disclosure relates to methods of administering OGFR antagonists locally to the site of cancer cells in the patient diagnosed with cancer."

The patent was filed on April 26, 2024, under Application No. 18/647,511.

*For furt...